Continuous Positive Airway Pressure Devices Market: Current Analysis and Forecast (2022-2030)

Continuous Positive Airway Pressure Devices Market: Current Analysis and Forecast (2022-2030)

Continuous positive airway pressure (CPAP) is a type of positive airway pressure ventilation in which a steady pressure larger than atmospheric pressure is continuously applied to a person's upper respiratory tract. The growth of the CPAP market is attributed due to several factors such as the rising prevalence of diabetes, high blood pressure, obesity, obstructive sleep apnea (OSA), and pulmonary disorders, such as dyspnea globally, which is to higher demand for CPAP devices. For instance, according to the Centers for Disease Control and Prevention's Behavioral Risk Factors Surveillance System (BFRSS) 2019, the adult obesity percentage in the United States was 42.4%. This was the first time the national average surpassed 40%.

The continuous positive airway pressure market is expected to grow at a steady rate of around 6.4% owing to the increasing number of sleep apnea cases and related conditions and the surging geriatric population with respiratory diseases. Moreover, the global population is aging at a rapid pace, leading to an increased prevalence of respiratory diseases among the elderly population which is a prominent factor in the growth of the market. Also, older adults are more susceptible to respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea which will drive the demand for CPAP devices. For instance, in 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema.

• Based on component, the market is segmented into CPAP masks, CPAP humidifiers, and others. Among them, the CPAP humidifiers category dominated the market in 2021. CPAP humidifiers are an essential accessory for CPAP machines and are driving the growth of the CPAP devices market. The increasing prevalence of sleep apnea and other respiratory disorders, the growing awareness of the benefits of CPAP therapy, and the increasing availability of affordable and portable CPAP devices are some of the key factors contributing to the market's growth.
• Based on application, the market is bifurcated into sleep apnea and COPD. Among them, the sleep apnea category dominated the market in 2022 owing to the growing obstructive sleep apnea (OSA) cases in the geriatric population and the rising awareness for OSA or other respiratory diseases will drive the growth of the market during the forecast period. For instance, according to the data published by the European Respiratory Society, approximately 13.0% to 32.0% of the geriatric population in Europe was suffering from sleep apnea.
• Based on end-user, the market is segmented into hospitals & clinics, home care, and others. Among them, the home care category dominated the market in 2022. This is mainly due to the players in the market concentrating on launching new, portable devices that can be used at home among those undergoing treatment for the condition. This, along with a growing preference for treating OSA at home, is driving up demand for these devices in-home care and other settings, particularly in countries like the U.S., the U.K., Germany, and Japan, among others.
• For a better understanding of the market adoption of the continuous positive airway pressure industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is expected to dominate the global CPAP devices market during the forecast period due to the presence of well-established healthcare infrastructure and higher adoption of technology in the country. Also, the country is witnessing the growing burden of sleep apnea which in turn is facilitating the CPAP devices market growth. For instance, according to sleep apnea org, It is estimated that 22 million Americans suffer from sleep apnea, with 80 percent of the cases of moderate and severe obstructive sleep apnea undiagnosed.
• Some of the major players operating in the market include BMC; ResMed; Fisher & Paykel Healthcare Limited; Drive DeVilbiss Healthcare; Shanghai Fosun Pharmaceutical Group Co., Ltd.; Smiths Group plc; Airing; Koninklijke Philips N.V.; Honeywell International Inc.; and Transcend, Inc.

The continuous positive airway pressure devices market was valued at USD 2233.85 million in the year 2022 and is expected to grow at a strong CAGR of around 6.4% during the forecast period owing to the growing obstructive sleep apnea (OSA) cases in the geriatric population and the rising awareness for OSA or other respiratory diseases. Continuous positive airway pressure (CPAP) is a type of positive airway pressure ventilation in which a steady pressure larger than atmospheric pressure is continuously applied to a person's upper respiratory tract. The growth of the CPAP market is attributed due to several factors such as the rising prevalence of diabetes, high blood pressure, obesity, obstructive sleep apnea (OSA), and pulmonary disorders, such as dyspnea globally, which is to higher demand for CPAP devices. For instance, according to the Centers for Disease Control and Prevention's Behavioral Risk Factors Surveillance System (BFRSS) 2019, the adult obesity percentage in the United States was 42.4%. This was the first time the national average surpassed 40%. The growing prevalence of obesity increases the demand for sleep apnea, thereby driving the market for continuous positive airway pressure market. Also, increased affordability with a rise in disposable income, an aging population, a surge in high levels of air pollution, and technological advancements in the region contribute to its outstanding share in the global market revenue during the forecast period.

Some of the major players operating in the market include BMC; ResMed; Fisher & Paykel Healthcare Limited; Drive DeVilbiss Healthcare; Shanghai Fosun Pharmaceutical（Group）Co., Ltd.; Smiths Group plc; Airing; Koninklijke Philips N.V.; Honeywell International Inc.; and Transcend, Inc. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst component, the smart appliances segment held a dominating share of the market in 2022”

Based on component, the market is segmented into CPAP masks, CPAP humidifiers, and others. Among them, the CPAP masks category is expected to grow at the fastest rate during the forecast period. CPAP masks are a critical component of the CPAP device that directly interfaces with the patient. The availability of a wide range of mask options, including nasal masks, full-face masks, and nasal pillows, caters to the diverse needs and preferences of individuals using CPAP therapy. Comfortable and well-fitting masks enhance patient compliance and satisfaction, leading to increased usage and improved therapy outcomes. Manufacturers that invest in research and development to innovate mask designs, improve seal performance, reduce noise levels, and enhance user comfort will have a competitive edge in the market. For instance, In April 2022, Fisher & Paykel Healthcare launched the F&P Evora Full in the US, a compact full-face mask for OSA.

“Amongst end-user, the home care category dominated the market in 2022”

Based on end-user, the market is segmented into hospitals & clinics, home care, and others. Among them, the home care category dominated the market in 2022. This is mainly due to the players in the market concentrating on launching new, portable devices that can be used at home among those undergoing treatment for the condition. This, along with a growing preference for treating OSA at home, is driving up demand for these devices in-home care and other settings, particularly in countries like the U.S., the U.K., Germany, and Japan, among others.

“APAC region is expected to grow significantly in the coming years”

The continuous positive airway pressure devices CDMO market in the APAC region is expected to grow significantly in the coming years due to several drivers such as the increasing diagnosis of sleep disorders & respiratory diseases, and technological advancements, such as improved device usability, quieter operation, and enhanced data tracking, contribute to the expanding market by enhancing patient comfort and compliance. Furthermore, there are several major players in the market for continuous positive airway pressure therapy, which is moderately competitive. In terms of revenue, some of the most prominent players in the market are aggressively making acquisitions and others are introducing new products. For instance, ResMed helped millions of South Koreans with sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions by acquiring HB Healthcare (HBH) in March 2019 to strengthen its leadership position in the CPAP and respiratory care market in Korea.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.